{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:19:34Z","timestamp":1761311974724},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["theclinics.com","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing Clinics of North America"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.cnur.2023.02.009","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T20:21:49Z","timestamp":1682454109000},"page":"165-181","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Substance Use Disorders and Medication-Assisted Therapies"],"prefix":"10.1016","volume":"58","author":[{"given":"Courtney","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anisa","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cnur.2023.02.009_bib1","first-page":"6","article-title":"Treatment of opioid use disorder among commercially insured U.S. adults, 2008\u201317","volume":"39","author":"Shen","year":"2022","journal-title":"Health Aff"},{"key":"10.1016\/j.cnur.2023.02.009_bib2","unstructured":"SAMHSA. About us. 2022. Available at: https:\/\/www.samhsa.gov\/about-us. Accessed October 11, 2022."},{"key":"10.1016\/j.cnur.2023.02.009_bib3","doi-asserted-by":"crossref","unstructured":"Anderson KN, Swedo EA, Trinh E, et al. Adverse childhood experiences during the COVID-19 pandemic and associations with poor mental health and suicidal behaviors among high school students \u2014 Adolescent Behaviors and Experiences Survey, United States, January-June 2021. US Department of Health and Human Services\/Centers for Disease Control and Prevention. MMWR, 71 (41), October 1.","DOI":"10.15585\/mmwr.mm7141a2"},{"key":"10.1016\/j.cnur.2023.02.009_bib4","article-title":"Once The coronavirus pandemic subsides, The opioid epidemic will rage","author":"Kang","year":"2020","journal-title":"Health Aff"},{"key":"10.1016\/j.cnur.2023.02.009_bib5","unstructured":"SAMSHA. Medication-assisted treatment: statutes, regulations, and guidelines. 2022. Available at: https:\/\/www.samhsa.gov\/medication-assisted-treatment\/statutes-regulations-guidelines. Accessed October 31, 2022."},{"key":"10.1016\/j.cnur.2023.02.009_bib6","series-title":"Substance abuse prevention dollars and cents: a cost-benefit analysis, DHHS Pub. No. (SMA) 07\u20134298","author":"Miller","year":"2008"},{"key":"10.1016\/j.cnur.2023.02.009_bib7","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/j.cnur.2023.02.009_bib8","first-page":"844","article-title":"Synaptic plasticity and addiction","volume":"8","author":"Kauer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cnur.2023.02.009_bib9","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiology Reviews"},{"key":"10.1016\/j.cnur.2023.02.009_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"NEJM"},{"issue":"5","key":"10.1016\/j.cnur.2023.02.009_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1017\/S0033291714002165","article-title":"The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies","volume":"45","author":"Verhulst","year":"2015","journal-title":"Psychol Med"},{"issue":"3","key":"10.1016\/j.cnur.2023.02.009_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.31887\/DCNS.2017.19.3\/wberrettini","article-title":"A\u00a0brief review of the genetics and pharmacogenetics of opioid use disorders","volume":"19","author":"Berrettini","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.cnur.2023.02.009_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archpsyc.60.9.929","article-title":"The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women","volume":"60","author":"Kendler","year":"2003","journal-title":"Arch Gen Psychiatr"},{"issue":"6","key":"10.1016\/j.cnur.2023.02.009_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1192\/bjp.170.6.541","article-title":"The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: A family history study","volume":"170","author":"Kendler","year":"2018","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.cnur.2023.02.009_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0749-3797(98)00017-8","article-title":"Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the adverse childhood experiences (ACE) study","volume":"14","author":"Felitti","year":"1998","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.cnur.2023.02.009_bib16","first-page":"e356","article-title":"The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis","volume":"2","author":"Hughes","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cnur.2023.02.009_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/acer.14772","article-title":"Evaluating risk for alcohol use disorder: Polygenic risk scores and family history","volume":"46","author":"Lai","year":"2022","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.cnur.2023.02.009_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41588-018-0307-5","article-title":"Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use","volume":"51","author":"Liu","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.cnur.2023.02.009_bib19","year":"2022","journal-title":"Adverse Childhood Experiences (ACEs)"},{"key":"10.1016\/j.cnur.2023.02.009_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3758\/s13415-021-00901-0","article-title":"Early life stress and neural development: Implications for understanding the developmental effects of COVID-19","volume":"22","author":"Smith","year":"2022","journal-title":"Cognit Affect Behav Neurosci"},{"issue":"3","key":"10.1016\/j.cnur.2023.02.009_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/alcalc\/36.3.249","article-title":"The course of anxiety, depression, and drinking behaviors after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders","volume":"36","author":"Driessen","year":"2001","journal-title":"Alcohol Alcohol"},{"issue":"15","key":"10.1016\/j.cnur.2023.02.009_bib22","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.291.15.1887","article-title":"Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis","volume":"291","author":"Nunes","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cnur.2023.02.009_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1521-0391.2011.00140.x","article-title":"Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence","volume":"20","author":"Hobbs","year":"2010","journal-title":"On Addictions"},{"key":"10.1016\/j.cnur.2023.02.009_bib24","series-title":"Nida. Principles of drug addiction treatment: a research-based guide","year":"2018"},{"key":"10.1016\/j.cnur.2023.02.009_bib25","series-title":"Data on substance abuse treatment facilities","year":"2013"},{"issue":"5","key":"10.1016\/j.cnur.2023.02.009_bib26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995\u20132009","volume":"103","author":"Schwartz","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.cnur.2023.02.009_bib27","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"6","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"September","key":"10.1016\/j.cnur.2023.02.009_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cct.2016.08.004","article-title":"NIDA Clinical Trials Network CTN-0051, Extended-release naltrexone vs. buprenorphine for opioid treatment (X:BOT): study design and rationale","volume":"50","author":"Lee","year":"2016","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"10.1016\/j.cnur.2023.02.009_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorder","volume":"375","author":"Schuckit","year":"2016","journal-title":"NEJM"},{"key":"10.1016\/j.cnur.2023.02.009_bib30","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2021"},{"issue":"1","key":"10.1016\/j.cnur.2023.02.009_bib31","first-page":"21","article-title":"Adoption and implementation of medications in addiction treatment programs","volume":"5","author":"Knudson","year":"2011","journal-title":"J\u00a0Addict Med"},{"issue":"14","key":"10.1016\/j.cnur.2023.02.009_bib32","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1007\/s11606-021-07274-7","article-title":"Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): an implementation trial in eight Veterans Health Administration Facilities","volume":"37","author":"Hagedorn","year":"2022","journal-title":"J\u00a0Gen Intern Med"},{"issue":"10","key":"10.1016\/j.cnur.2023.02.009_bib33","doi-asserted-by":"crossref","first-page":"e2236904","DOI":"10.1001\/jamanetworkopen.2022.36904","article-title":"Effect of implementation facilitation to promote adoption of medications for addiction treatment in US HIV Clinics","volume":"5","author":"Edelman","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.cnur.2023.02.009_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.cnur.2023.02.009_bib35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0304-3959(89)90097-3","article-title":"Opioid pseudoaddiction \u2014 an iatrogenic syndrome","volume":"36","author":"Weissman","year":"1989","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.cnur.2023.02.009_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/JAN.0b013e318271c123","article-title":"American Society for Pain Management Nursing Position Statement: Pain management in patients with substance use disorders","volume":"23","author":"Oliver","year":"2012","journal-title":"J\u00a0Addict Nurs"},{"issue":"4","key":"10.1016\/j.cnur.2023.02.009_bib37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.jcp.0000132347.81455.57","article-title":"interval prolongation in patients on methadone with concomitant drugs","volume":"24","author":"Piguet","year":"2004","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.cnur.2023.02.009_bib38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2006.01512.x","article-title":"Methadone-associated torsade de pointes (polymorphic ventricular tachycardia) in opioid-dependent patients","volume":"101","author":"Justo","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.cnur.2023.02.009_bib39","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.166.12.1280","article-title":"Drug-induced long QT syndrome in injection drug users receiving methadone","volume":"166","author":"Ehret","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cnur.2023.02.009_bib40","series-title":"ACLS provider manual","year":"2017"},{"issue":"8","key":"10.1016\/j.cnur.2023.02.009_bib41","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1526-4637.2012.01406.x","article-title":"The clinical significance of Q.T. interval prolongation in anesthesia and pain management: what you should and should not worry about","volume":"13","author":"Spevak","year":"2006","journal-title":"Pain Med"},{"key":"10.1016\/j.cnur.2023.02.009_bib42","first-page":"CD001867","article-title":"Opioid antagonists for alcohol dependence","volume":"12","author":"Rosner","year":"2010","journal-title":"Cochrane Database of Systemic Reviews"},{"key":"10.1016\/j.cnur.2023.02.009_bib43","first-page":"2016","article-title":"ANTABUSE: Disulfiram tablet","volume":"23","year":"2016","journal-title":"Daily Med"},{"issue":"2","key":"10.1016\/j.cnur.2023.02.009_bib44","doi-asserted-by":"crossref","first-page":"e87366","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol use disorder: A meta-analysis","volume":"9","author":"Skinner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cnur.2023.02.009_bib45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/npp.2015.142","article-title":"Stress-induced reinstatement of drug seeking: 20 years of progress","volume":"41","author":"Mantsch","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cnur.2023.02.009_bib46","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/archgenpsychiatry.2011.49","article-title":"Effects of adrenal sensitivity, stress- and cue-induced craving and subsequent relapse and treatment outcomes","volume":"68","author":"Sinha","year":"2011","journal-title":"Arch Gen Psychiatr"},{"issue":"5","key":"10.1016\/j.cnur.2023.02.009_bib47","first-page":"CD002024","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal (Review)","volume":"2016","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.cnur.2023.02.009_bib48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-015-0423-9","article-title":"Acamprosate: A review of its use in alcohol dependence","volume":"75","author":"Plosker","year":"2015","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.cnur.2023.02.009_bib49","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1176\/appi.ajp.2013.13050709","article-title":"Antidepressant-induced liver injury: A review for clinicians","volume":"171","author":"Volcan","year":"2014","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.cnur.2023.02.009_bib50","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/PAS.0b013e31826af296","article-title":"Venlafaxine-induced cholestatic hepatitis: case report and review of the literature. American","volume":"36","author":"Standlmann","year":"2012","journal-title":"Journal of Surgery & Pathology"},{"key":"10.1016\/j.cnur.2023.02.009_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pharmthera.2017.11.007","article-title":"Medications for alcohol use disorders: an overview","volume":"185","author":"Akbar","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.cnur.2023.02.009_bib52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","author":"Mason","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cnur.2023.02.009_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/alcalc\/agr153","article-title":"Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized, placebo-controlled trial","volume":"47","author":"Forg","year":"2012","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"10.1016\/j.cnur.2023.02.009_bib54","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1530-0277.2011.01649.x","article-title":"A\u00a0double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate X.R. in very heavy drinking alcohol-dependent patients","volume":"36","author":"Litten","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"10.1016\/j.cnur.2023.02.009_bib55","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/acer.12445","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence","volume":"38","author":"Brown","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"68","key":"10.1016\/j.cnur.2023.02.009_bib56","first-page":"1","article-title":"R(+)-baclofen, but not S(-)-baclofen, alters alcohol self-administration in alcohol-preferring rats","volume":"7","author":"Lorrai","year":"2016","journal-title":"Front Psychiatr"},{"issue":"4","key":"10.1016\/j.cnur.2023.02.009_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/alcalc\/agx030","article-title":"A\u00a0randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients-The ALPADIR study","volume":"52","author":"Reynaud","year":"2017","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.cnur.2023.02.009_bib58","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/acer.13157","article-title":"Combining varenicline (Chantix) with naltrexone decreases alcohol drinking more effectively than does either drug alone in a rodent model of alcoholism","volume":"40","author":"Froehlich","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cnur.2023.02.009_bib59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00213-012-2717-x","article-title":"Varenicline decreases alcohol consumption in heavy-drinking smokers","volume":"223","author":"Mitchell","year":"2012","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.cnur.2023.02.009_bib60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":"A\u00a0double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence","volume":"7","author":"Litten","year":"2013","journal-title":"J\u00a0Addiction Med"},{"issue":"10","key":"10.1016\/j.cnur.2023.02.009_bib61","first-page":"CD011611","article-title":"Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults","volume":"10","author":"McCloud","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cnur.2023.02.009_bib62","doi-asserted-by":"crossref","first-page":"813103","DOI":"10.3389\/fpsyt.2022.813103","article-title":"The Multivariate Effect of Ketamine on PTSD: Systematic Review and Meta-Analysis","volume":"13","author":"Du","year":"2022","journal-title":"Front Psychiatr"},{"issue":"10","key":"10.1016\/j.cnur.2023.02.009_bib63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1213\/ANE.0000000000004185","article-title":"Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials","volume":"129","author":"Orhurhu","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cnur.2023.02.009_bib64","doi-asserted-by":"crossref","first-page":"107845","DOI":"10.1016\/j.drugalcdep.2020.107845","article-title":"Clinical benefits and risks of N-methyl-D-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review","volume":"208","author":"Fluyau","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.cnur.2023.02.009_bib65","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s12325-017-0546-3","article-title":"Nalmefene in alcohol use disorder subjects with psychiatric comorbidity: A naturalistic study","volume":"34","author":"Di Nicola","year":"2017","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.cnur.2023.02.009_bib66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/YIC.0000000000000170","article-title":"Use of nalmefene in patients with comorbid borderline personality disorder and alcohol use disorder: A preliminary report","volume":"32","author":"Martin-Blanco","year":"2017","journal-title":"Int Clin Psychopharmacol"}],"container-title":["Nursing Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0029646523000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0029646523000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T03:33:23Z","timestamp":1682480003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0029646523000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0029646523000154"],"URL":"https:\/\/doi.org\/10.1016\/j.cnur.2023.02.009","relation":{},"ISSN":["0029-6465"],"issn-type":[{"value":"0029-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance Use Disorders and Medication-Assisted Therapies","name":"articletitle","label":"Article Title"},{"value":"Nursing Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cnur.2023.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}